
News|Articles|September 18, 2024
Growth Factor Supplementation: A New Paradigm in Ocular Surface Disease Management
Advertisement
Sponsored Supplement:
Growth factors play a crucial role in maintaining ocular surface homeostasis and health and promoting healing in various ocular disorders. As our understanding of these molecules evolves, so does their potential for therapeutic application. To explore the current state of knowledge and clinical practice regarding growth factors in ocular surface disease, Vital Tears recently convened a roundtable discussion with five internationally renowned clinicians specializing in dry eye and ocular surface disorders: Clara Chan, Minas Coroneo, Pedram Hamrah, Victor L. Perez, and Stephen Pflugfelder.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Lumvoa (veligrotug-vvze) for active and chronic thyroid eye disease
2
Myopia as a lifelong vision health condition: Long-term ocular risks and modern management strategies
3
AOA 2026: What fitting patients for comfortability looks like in daily practice
4
AOA 2026: Do researchers lie?
5
























